“…2.3.1. Single-Biomarker Studies.Due to the complexity of the matrices and the physicochemical diversity of mycotoxins, most of the methods currently used to analyze these toxins in human plasma and serum samples focus on assaying one mycotoxin or some structurally related mycotoxins belonging to a single family, such as AFs (AFB1, AFB2, AFG1, AFG2, AFB1-lys)[49,57,64,65,[75][76][77][78][79]81,82,[86][87][88][89][90][91][92][112][113][114][115][116][117], OTA and OTα[54,55,[61][62][63]85,118,119], CIT and DH-CIT[23,[54][55][56] and ZEA and its metabolites[58,68,69].…”